NWBO - Northwest Biotherapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
1,086
1,683
1,005
1,291
2,410
Operating Expense
60,765
68,864
53,707
87,896
29,873
Operating Income
-59,679
-67,181
-52,702
-86,605
-27,463
Net Non Operating Interest Income Expense
-6,000
-6,068
-5,011
-8,544
-2,975
Other Income Expense
122,265
-31,783
236,839
-434,672
10,142
Pretax Income
56,586
-105,032
179,126
-529,821
-20,296
Net Income Common Stockholders
56,586
-105,032
179,126
-529,821
-20,296
Diluted NI Available to Com Stockholders
56,586
-105,032
179,126
-529,821
-20,296
Basic EPS
-
-0.10
0.21
-0.73
-0.04
Diluted EPS
-
-0.10
-0.06
-0.73
-0.04
Basic Average Shares
-
1,015,852
873,517
725,129
564,188
Diluted Average Shares
-
1,015,852
1,007,869
725,129
564,188
Total Operating Income as Reported
-59,679
-67,181
-52,702
-86,605
-27,463
Total Expenses
60,765
68,864
53,707
87,896
29,873
Net Income from Continuing & Discontinued Operation
56,586
-105,032
179,126
-529,821
-20,296
Normalized Income
-16,973
-73,216
5,761
-95,149
-30,438
Interest Expense
6,000
6,068
5,011
8,544
2,975
Net Interest Income
-6,000
-6,068
-5,011
-8,544
-2,975
EBIT
62,586
-98,964
184,137
-521,277
-17,321
EBITDA
63,844
-
-
-
-
Reconciled Depreciation
1,258
1,500
586
425
-301
Net Income from Continuing Operation Net Minority Interest
56,586
-105,032
179,126
-529,821
-20,296
Total Unusual Items Excluding Goodwill
122,598
-31,816
237,486
-434,672
10,142
Total Unusual Items
122,598
-31,816
237,486
-434,672
10,142
Normalized EBITDA
-58,754
-65,648
-52,763
-86,180
-27,463
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
49,039
0
64,121
0
0

Yahoo Finance Plus Essential access required.

Learn more